Silica Resins
Description
Sepax manufactures wide range of silica based media with the particle size selection of 5, 10, 15, 20,
30, 50 and 60 µm spherical particles with pore size selection of 60, 120, 200, 300, 500 and 1000 Å.
The bonding chemistry is from regular C18, C8, C4, Phenyl, Cyano, Amino, Diol, Pyridine, SCX and
SAX to any custom-synthesis. The controlled manufacturing process guarantees high batch-to-batch
reproducibility. Their high surface area and high mechanical strength enable those media ideal for
preparative separation and purification.
Packing
Phases
|
Chemistry
|
Particle
Size
(µm)
|
Pore
Size
(Å)
|
Surface
Area
(m²/g)
|
Carbon
Loading
(%)
|
pH
Stability
|
Bonding
|
C18
|
GP-C18
|
5, 10, 15, 20,
30, 50
|
60
120
|
450
300
|
19
17
|
2-8.5
|
Monomeric and
fully endcapped
|
|
BR-C18
|
5, 10
|
120
|
300
|
19
|
1.5-10.5
|
Fully endcapped
|
|
HP-C18
|
5, 10, 15, 50
|
120
|
300
|
15
|
2-8.5
|
Monomeric and
fully endcapped
|
|
Bio-C18
|
5, 10, 15, 50
|
200
300
|
200
105
|
10
8.5
|
2-8.5
|
Monomeric and
fully endcapped
|
C8
|
GP-C8
|
5, 10, 15, 50
|
60
120
|
450
300
|
15
11
|
2-8.5
|
Monomeric and
fully endcapped
|
|
Bio-C8
|
5, 10, 15, 50
|
300
|
105
|
5.2
|
2-8.5
|
Monomeric and
fully endcapped
|
C4
|
GP-C4
|
5, 10, 15, 50
|
120
|
300
|
8.0
|
2-8.5
|
Monomeric and
fully endcapped
|
|
Bio-C4
|
5, 10, 15, 50
|
300
|
105
|
3.1
|
2-8.5
|
Monomeric and
fully endcapped
|
Phenyl
|
GP-Phenyl
|
5, 10, 15, 50
|
120
|
300
|
11
|
2-8.5
|
Monomeric and
fully endcapped
|
CN
|
HP-Cyano
|
5, 10, 15, 50
|
120
|
300
|
7.0
|
2-8.5
|
Monomeric and
fully endcapped
|
NH2
|
HP-Amino
|
5, 10, 15, 50
|
120
|
300
|
4.2
|
2-8.5
|
Polymeric and
no endcapping
|
SO3H
|
HP-SCX
|
5, 10, 15, 50
|
120
|
300
|
11
|
2-8.5
|
Monomeric and
fully endcapped
|
Silica
|
HP-Silica
|
5, 10, 15, 20,
30, 50, 60
|
60
120
300
|
450
300
100
|
0.0
0.0
0.0
|
2-8.5
|
Activated surface
|
Characteristic
· Available in both reversed and normal phases
· High chemical stability for low leaching
· High loading capacity
· High mechanical strength for multiple packing
· Spherical particles with controlled pore sizes
· Available from grams to multi-Kilogram
· More than 20 different chemistries
Application
Phases
|
Chemistry
|
Applications
|
C18
|
GP-C18
|
Reversed phase separations for pharmaceuticals, nutraceuticals,
natural products, acidic, neutral and basic compounds
|
BR-C18
|
Basic compounds or separations required high pH durability
|
HP-C18
|
Separations at high aqueous mobile phase, pharmaceuticals, vitamins,
natural products, peptides, and polar compounds
|
Bio-C18
|
Separations required large pore size or at high aqueous mobile phase,
pharmaceuticals, vitamins, natural products, peptides, and polar compounds
|
C8
|
GP-C8
|
Reversed phase separations for pharmaceuticals, estrogens,
acidic, neutral and basic compounds
|
Bio-C8
|
Separations required large pore size for pharmaceuticals, vitamins,
proteins, peptides, and polar compounds
|
C4
|
GP-C4
|
Proteins and peptides
|
Bio-C4
|
Separations required large pore size for proteins and peptides
|
Phenyl
|
GP-Phenyl
|
Aromatic compounds, antibiotics, lipids, ring-structured compounds
|
CN
|
HP-Cyano
|
Normal phase separations for pharmaceuticals and polar
organic compounds
|
NH2
|
HP-Amino
|
Sugars, alcohols, vitamins, nucleosides, oligonucleotides,
and anionic compounds
|
SO3H
|
HP-SCX
|
Amine and polyamine containing compounds, nucleotides, and peptides
|
Silica
|
HP-Silica
|
Normal phase or HILIC mode separation for basic compounds,
pharmaceuticals, nutraceuticals, and metabolites
|
bio-equip.cn
Profile
Sepax Technologies, Inc., a privately held company, was founded in Delaware, USA in November 2002. It develops and manufactures HPLC consumables, bulk media, and equipment in liquid chromatography for chemical and biological separations. It is a fast growing technology company and owns patents, proprietary technologies and know-how. Sepax has emerged as a leader in the biological separation industry in the global market.
Business strategies
Sepax Technologies, Inc. develops innovative HPLC consumables, bulk media, and instruments to solve separation challenges in the global market. We provide solution-based products by closely working with our customer scientists in pharmaceuticals, biopharmaceuticals, research institutes and government labs. Our strong technical team develops various methods with our customers to analyze complex biological molecules. As a leader in the biological separation industry, we constantly develop the best bio-separation technologies and products for our global customers. We have reached a competitive position globally in fast growing regions.
Vision Statement
To become a technology leader in the biological separation industry in the global market and provide solution based products and services for our customers.
Operation
Sepax Technologies, Inc.
Our company headquarter in Delaware is located in Delaware Technology Park with facilities of 15,000 ft2 dedicated to the development of separation resin technologies and instrumentation, production of HPLC resins, columns and CE consumables. It is also the marketing and sales center for our US and global markets.
Sales
Domestic
Audrey Fisher
Field Sales Account Manager
(Northern CA areas, UT, CO, OR)
Direct Phone: 925-324-5223
Email: afisher@sepax-tech.com
Kathleen Falls
West Coast Regional Manager
(All other CA areas, WA, TX, AZ, NM, MI)
Direct Phone: 323-228-0004
Email: kfalls@sepax-tech.com
Michael Hunnewell
Field Sales Account Manager
(MA, RI, NH, CT, NY)
Direct Phone: 302-650-3955
Email: mhunnewell@sepax-tech.com
Colleen Callahan
Midwest Account Manager
(WI, IL, IN, OH, MO)
Direct Phone: 302-366-1101, ext 106
Cell Phone: 302-339-8747
Email: ccallahan@sepax-tech.com
All other areas, please contact
Helen Gu
Vice President, Sales
Direct phone: 302-650-3909
Email: hgu@sepax-tech.com
International
Tingting Wu
Executive Account Manager/Marketing
Phone: 302-366-1101, ext 115
Email: twu@sepax-tech.com
|